Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination (Virtual Meeting) Meeting Report and Recommendations

Total Page:16

File Type:pdf, Size:1020Kb

Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination (Virtual Meeting) Meeting Report and Recommendations Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination (Virtual Meeting) Meeting Report and Recommendations 14-15 October 2020 Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination, 14–15 October 2020. Meeting Report and Recommendations PAHO/CDE/HT/21-0009 © Pan American Health Organization, 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO license (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this license, this work may be copied, redistributed, and adapted for non-commercial purposes, provided the new work is issued using the same or equivalent Creative Commons license and it is appropriately cited. In any use of this work, there should be no suggestion that the Pan American Health Organization (PAHO) endorses any specific organization, product, or service. Use of the PAHO logo is not permitted. All reasonable precautions have been taken by PAHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall PAHO be liable for damages arising from its use. Contents Introduction ................................................................................................................................................... 2 1. Objectives .............................................................................................................................................. 2 2. Methodology and participants.............................................................................................................. 2 3. Positioning PAHO’s disease elimination initiative in the evolving context of COVID-19 ..................... 3 4. Promotion and operationalization of integrated health service delivery for disease elimination ...... 6 5. Conclusions and Recommendations ..................................................................................................... 7 APENDIX ....................................................................................................................................................... 13 Appendix 1. Members of STAG on Disease Elimination .............................................................................. 13 Appendix 2. List of participants ................................................................................................................... 14 Appendix 3. Background Document 1: Setting the Scene – The PAHO Disease Elimination Initiative and the Evolving Context of COVID-19 ............................................................................................................... 16 Appendix 4. Background document 2: Role and Importance of Operational Research in the context of the PAHO Disease Elimination Initiative ............................................................................................................ 22 Appendix 5. Milestones in the Elimination of Communicable Diseases in the Region of the Americas. 24 Appendix 6. Communicable diseases and related conditions candidates for elimination by 2030........ 25 Appendix 7. Agenda ................................................................................................................................. 26 Appendix 8. Group photo ................................................................................................................. 28 525 23rd St. NW, Washington, D.C., 20037 | +1 202-974-3453 | www.paho.org | 1 Introduction This report provides a summary of the proceedings, conclusions, and recommendations of the first meeting of the PAHO/WHO Strategic and Technical Advisory Group (STAG) on Disease Elimination. Throughout its history, the Pan American Health Organization (PAHO) has played a key role in supporting important disease elimination achievements in the Americas and globally. These achievements were made possible through the adoption of public health approaches that are spelled out in frameworks and sets of recommended disease-control interventions, providing for robust vaccination and mass drug administration programs for targeted neglected infectious diseases as well as, water and sanitation programs and housing quality and safety initiatives. To support the work ahead and reinforce PAHO`s leading role in the disease elimination efforts in the Americas, in October 2019 PAHO Member States endorsed the PAHO Disease Elimination Initiative and a Policy for an Integrated Sustainable Approach to Communicable Diseases in the Americas. The Elimination initiative provides a sustainable framework to orient and guide Member States towards elimination of a group of priority communicable diseases and related conditions. It envisions future generations free of the burden of a set of communicable diseases in the Americas, beginning no later than 2030. 1. Objectives - Provide advice on strategic interventions to enhance PAHO technical cooperation and accelerate regional response towards disease elimination. - Facilitate discussions regarding evolving issues and priorities for disease elimination in the Region, particularly amidst the evolving context of the COVID-19 pandemic and other potential future disruptions. 2. Methodology and participants A two-day virtual meeting was held on 14-15 October 2020 with the appointed members of the STAG and delegates of PAHO. A list of the STAG members is given in Appendix 1, while the list of participants is provided in Appendix 2. After introducing participants, presenting the terms of reference of the STAG (available at https://www.paho.org/en/destination-elimination), and appointing the Chair (Patricia Garcia) and Co- Chair (Patrick Lammie), members of the STAG discussed and provided recommendations to PAHO on the following two strategic questions: 525 23rd St. NW, Washington, D.C., 20037 | +1 202-974-3453 | www.paho.org | 2 - How can we strategically position the Disease Elimination Initiative (politically, financially, and technically) under and within the evolving context of COVID- 19? - How do we promote and operationalize integrated health service delivery towards disease elimination (especially at the primary healthcare level)? Members of the STAG discussed the available documents of PAHO’s disease elimination initiative (1,2) and two background papers, one for each of the strategic questions, prepared by PAHO’s Secretariat (Appendixes 3 and 4). A debriefing session was held on 15 October by the Chair, Co-Chair, some other members of the STAG, and PAHO delegates with Dr. Carissa Etienne, Director of PAHO, to present the recommendations. A detailed agenda of the meeting is available in Appendix 5 and a group photo in Appendix 6. 3. Positioning PAHO’s disease elimination initiative in the evolving context of COVID-19 After reviewing the background of PAHO’s disease elimination initiative, the steps taken and progress upon its approval by PAHO’s Directing Council in October 2019 (3), and discussing challenges including the evolving context of COVID-19 in the Region of the Americas, the following relevant issues were identified by members of the STAG as priorities for PAHO and countries to position the disease elimination initiative. • PAHO’s disease elimination initiative is relevant to protect the achievements toward disease control and elimination in the Region of the Americas and to accelerate efforts to overcome the challenges imposed by COVID-19 through the framework of health as a human right. Lessons learned from the pandemic, especially those in which community actions contributed to reinforce community-centered approaches, integrated delivery of health services, reinforcement of information systems, among others, should be used to strengthen national and local health capacities towards Universal Health. • PAHO can be catalytic in advocating and creating regional networks of partners, institutions, organizations, including community-based organizations, to reinforce the regional capacities to reach the disease elimination goals. It is important to improve the work on integration and primary health care, aiming at the quality of services and the elimination of diseases. The regional networks should include different levels within country governments, private sector, communities, and media, and should promote and sustain communities of practice. • Reinforcement of local frameworks adapted to local needs and contexts should be promoted by PAHO including key components of resilient health systems such as local empowerment, leadership and 525 23rd St. NW, Washington, D.C., 20037 | +1 202-974-3453 | www.paho.org | 3 governance, information systems, health workforce, access to essential medicines, delivery of services, and financing. Documenting investment cases for diseases elimination is an important advocacy tool to show the benefits of the initiative and the role played in strengthening health systems. • Health systems should reinforce the interaction between human, animal and environmental health, through the One Health framework, providing communities with the tools and conditions to monitor, prevent and early response to epidemic of zoonotic and/or vector borne diseases. • PAHO can help countries to identify priorities in the current pandemic context, starting with those diseases showing increased morbidity and mortality due
Recommended publications
  • DRAFT Guidelines for Behavior Change Interventions to Prevent HIV
    DRAFT Guidelines for Behavior Change Interventions to Prevent HIV Sharing Lessons from an Experience in Bangladesh Based on the Application of Lessons from Sonagachi, Kolkata. Best Practice Collection from the Region, UNAIDS South Asia Inter Country Team 1 Guidelines for Behavior Change Interventions to Prevent HIV-Sharing Lessons from an Experience in Bangladesh, Based on Applying learning from Sonagachi, India published by UNAIDS Inter Country Team for South Asia, New Delhi 2003- All rights reserved. This document, which is not a formal publication of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or full, provided the source is acknowledged. The document may not be sold or used in conjunction with commercial purposes without priori written approval of UNAIDS ( Contact: UNAIDS Information Center) The document expressed in documents any named authors are solely the responsibility of these authors. The designations employed and the presentation of the material in this work do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, testimony, city or area or of its authorities, or concerning the delimitation of its frontiers and boundaries The mention of specific organisations, companies or of certain manufacturers products does not imply that they are endorsed or recommended by UNAIDS in preference to others of a similar nature that are not mentioned . Errors and omissions are excepted, the names of proprietary products are distinguished by initial capital letters. Contributing Author: Geeta Sethi and Smarajit Jana Consulting Editor : Deepika Ganju Support in design and lay out: Enamul Haque & Yasmin Acknowledgements: This manual heavily draws from a training module written by CARE Bangladesh in 1997.
    [Show full text]
  • Epidemic of Abuse — Police Harassment
    July 2002 Vol 14, No 5 (C) INDIA EPIDEMIC OF ABUSE: POLICE HARASSMENT OF HIV/AIDS OUTREACH WORKERS IN INDIA [ADVANCE COPY] Table of Contents I. SUMMARY...........................................................................................................................................................3 II. RECOMMENDATIONS .....................................................................................................................................6 To the Government of India ...................................................................................................................................6 To the National AIDS Control Organisation..........................................................................................................6 To the World Bank, United Nations agencies and bilateral donors supporting HIV/AIDS programs in India: ....7 III. METHODS .........................................................................................................................................................7 IV. BACKGROUND: HIV/AIDS IN INDIA ...........................................................................................................8 V. ABUSES AGAINST HIV/AIDS OUTREACH WORKERS ............................................................................11 Human rights abuses linked to HIV/AIDS outreach to women in prostitution....................................................11 Human rights abuses linked to HIV/AIDS outreach to men who have sex with men..........................................19
    [Show full text]
  • Costing Guidelines for HIV/AIDS Intervention Strategies
    ADB - UNAIDS Study Series : Tool I Costing Guidelines for HIV/AIDS Intervention Strategies For use in estimating Resource Needs, Scaling-up and Strategic Planning in the Asia/Pacific region February 2004 This document is a collaborative work of the Asian Development Bank, UNAIDS, Futures Group International and Ease International and forms a part of the training material used to cost pre- vention and care activities at local, country and regional level. Contributors (in alphabetical or- der): Anita Alban, Michael Hahn, Catherine Hankins, Sigit Priohutomo, Myat Htoo Razak, DCS Reddy, Swarup Sarkar and John Stover. The primary spreadsheet INPUT for Nepal was pro- duced by Anita Alban and Michael Hahn; the regional version was developed by Vidya Ganesh, DCS Reddy and Shyam Sundar, editing and review by Adriana Gomez, Michael Hahn, Tony Lisle, Rebecca Moss, Lee-Nah Hsu, Rober Greenner and Swarup Sarkar. Views expressed in this document do not necessarily reflect the official position of UNAIDS and Asian Development Bank. UNAIDS/04.41E (English, original, February 2004) ISBN 974-91970-6-2 First Edition, February 2004 © Joint United Nations Programme on HIV/AIDS (UNAIDS) & Asian Development Bank (ADB), 2004 All rights reserved. This document, which is not a formal publication of UNAIDS and ADB, may be freely reviewed, quoted, reproduced or translated, in part or full, provided the source is acknowledged. The document may not be sold or used in conjunction with commercial pur- poses without prior written approval of UNAIDS or ADB (please contact the UNAIDS Information Centre, UNAIDS, Geneva or ADB, Manila). The views expressed in documents by named au- thors are the sole responsibility of those authors.
    [Show full text]
  • Mtg-Report-09-11-May-2018.Pdf (‎306.3Kb)
    Regional dissemination workshop on Guidelines for HIV and Hepatitis B & C New Delhi, India, 09 - 11 May 2018 Regional Office for South-East Asia 1 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.
    [Show full text]
  • Geographic Hotspots and Key Populations
    Identifying Populations at Greatest Risk of Infection – Geographic Hotspots and Key Populations Report and recommendations from a meeting of the UNAIDS Reference Group on Estimates, Modeling and Projections held in Geneva, Switzerland, 25-26 July 2013 1 Introduction The Joint United Nations Programme on HIV/AIDS (UNAIDS) Reference Group on Estimates, Modelling and Projections exists to provide impartial scientific advice to UNAIDS, the World Health Organization (WHO) and other partner organizations on global estimates and projections of the prevalence, incidence and impact of HIV/AIDS. The Reference Group acts as an ‘open cohort’ of epidemiologists, demographers, statisticians, and public health experts. It is able to provide timely advice and also address ongoing concerns through both ad hoc and regular meetings. The group is coordinated by a secretariat based in the Department of Infectious Disease Epidemiology, Imperial College London. Meeting objectives The main objectives of this consultation are to: 1. Discuss and advise whether and how a more granular representation of prevalence, incidence and risk at different administrative levels could better convey the need for programming in line with the nature of the local epidemic. 2. Discuss and advise how improvements can be made in the analysis and presentation of the manifold higher risk of infection of key populations compared to the rest of the population in different parts of the world, in view of triggering action, and in view of changing epidemic trends. 3. Discuss and assess the potential impact of applying geographical data analysis to improve programme efficiency. Three main outcomes will be developed following the meeting: 1. Meeting report 2.
    [Show full text]
  • Men Who Have Sex with Men the Missing Piece in National Responses to AIDS in Asia and the Pacific UNAIDS
    Men who have sex with men the missing piece in national responses to AIDS in Asia and the Pacific UNAIDS UNAIDS (English original, July 2007) © Joint United Nations Programme on HIV/AIDS (UNAIDS) 2007. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. UNAIDS does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. UNAIDS RSTAP 9th Floor, Block A, United Nations Building, Rajdamnern Nok Avenue, Bangkok 10200, Thailand Tel: 66 (0) 2288 2497-8 Fax: 66 (0) 2288 1092 20 avenue Appia, CH-1211 Geneva 27, Switzerland Tel: (+41) 22 791 36 66 Fax: (+41) 22 791 48 35 Email: [email protected] Website: www.unaids.org UNAIDS Acknowledgements This paper was written as a background paper for “Male Sexual Health and HIV in Asia and the Pacific International Consultation: Risks and Responsibilities,” held in New Delhi, India, 22nd -26th September 2006. UNAIDS gratefully acknowledges the advice, guidance and support given by the MSM and Transgender community members involved all across the region without whose support this publication would not have been possible. Many colleagues in UNAIDS country and Geneva offices also helped in editing the publication. We express special gratitude to the following persons who significantly contributed to this publication, namely: Aditya Bondyoapdhyay, Andrew Wilson, Billy Pick, Clif Cortez, David Bridger, Frits van Griensven, Gayle Martin, Geoff Manthey, Jan W de Lind van Wijngaarden, Michel Carael, Paul Causey, Phillippe Girault, Purnima Mane, Shivananda Khan, Swarup Sarkar, Tim Brown and Tracey Newbury.
    [Show full text]
  • Evaluation of the Indonesian Aksi Stop Aids Program
    PROCUREMENT SENSITIVE INFORMATION NOT FOR PUBLIC RELEASE UNTIL JANUARY 2009 EVALUATION OF THE INDONESIAN AKSI STOP AIDS PROGRAM Submitted to USAID/Jakarta by Jack Reynolds, The Synergy Project Gani Perla, The Synergy Project Suriadi Gunawan, The Synergy Project Izhar Fihir, The Synergy Project Elapully Haran, The Synergy Project Billy Pick, USAID/ANE/TS Ratna Kurniawati, USAID/Indonesia Lisa Kramer, USAID/Indonesia Jeanne Uktolseja, MOH/CDC Swarup Sakar, UNAIDS October 2004 EXECUTIVE SUMMARY Scope of Work: Over a three-week period, a 10-person team conducted an evaluation of the Aksi Stop AIDS (ASA) program. The evaluation concentrated on achievement of the program’s five Results Packages. The fundamental question was whether or not ASA should be continued, either as designed or with modifications. The team spent the first week interviewing ASA staff and other informants, the second week visiting implementing agencies (IAs) in Papua, North Sulawesi, and Central Java. Most of the third week was spent drafting the report and debriefing USAID, ASA, the Ministry of Health (MOH), and others. The Epidemiological Situation: Indonesia’s epidemic remains a concentrated one, with the possible exception of Papua, which appears to be spreading to the general population. In addition to Papua, the provinces with the largest number of infections appear to be Jakarta DKI and East Java. The groups most at risk are injecting drug users (IDUs), clients of female sex workers, partners of high-risk groups, men who have sex with men (MSM), female sex workers (FSW), and transvestites. Behavioral surveillance surveys have shown that knowledge about HIV/AIDS is high, but that this knowledge has little effect on behavior.
    [Show full text]
  • GHSN Quarterly Newsletter
    GHSN Quarterly Newsletter Q2 January 2021 In this Issue • Happy New Year • Introducing the GHSN Board • Call for Action #SustainWHO • Latest Global Health Meetings • Latest Health Security News • GHSN Sponsors Happy New Year Our Mission 2021 is finally upon us and many will be relieved to see the back Our mission is to create an international of 2020! community of academics, scientists and policy- makers who seek to share their knowledge and It was a big year for the GHSN with our official launch 7 months research on global health security. ago, and we are so grateful for our fantastic members and the support we have received from them. We encourage free thinking and support those that wish to make a meaningful impact to The GHSN has lots of exciting plans in place for 2021, kicking the improve the health and well-being of all people year off with the release of our 2nd policy report which will globally. discuss vaccine misinformation. We also have many interesting speakers lined up for our fortnightly webinars. Keep an eye out The GHSN community is an opportunity to on our website for more details! engage with members, sharing their ideas through the Association and at GHSN events We hope you have a fantastic year ahead and would like to take around the world. the opportunity to thank you again for your continued support. The Global Health Security Network Board A/Prof Adam Kamradt-Scott Adam specialises in global health security and international relations. His research and teaching explore how governments and multilateral organisations cooperate and interact when adverse health events such as disease outbreaks, epidemics and pandemics occur, as well as how they respond to emerging health and security challenges.
    [Show full text]
  • Rapid Assessment and Response Guide on Injecting Drug Use (IDU-RAR)
    WHO/HSC/SAB Original: English Distr.: Limited . Draft for field testing, MAY 1998 SUBSTANCE ABUSE DEPARTMENT The Rapid Assessment and Response guide on injecting drug use (IDU-RAR) SOCIAL CHANGE AND MENTAL HEALTH WORLD HEALTH ORGANIZATION This guide was prepared for the World Health Organization Substance Abuse Department (WHO/SAB) It was prepared by Professor Gerry V. Stimson, Chris Fitch and Tim Rhodes, at the The Centre for Research on Drugs and Health Behaviour Department of Social Science and Medicine Imperial College School of Medicine London, United Kingdom Technical support/contributions were provided by: Moruf Adelekan (University of Ilorin, Nigeria) Andrew Ball (WHO/SAB) Martin Donoghoe (WHO/SAB) Augusto Perez-Gomez (Universidad de los Andes, Colombia) Sujata Rana (WHO/SAB and UNAIDS/PSR) Swarup Sarkar (UNAIDS) Gundo Aurel Weiler (WHO/SAB) THIS IS A DRAFT DOCUMENT. USERS ARE REQUESTED TO PROVIDE ANY FEEDBACK AND COMMENTS TO WHO/SAB Provisional reference details: World Health Organization - Substance Abuse Department (1998) The Rapid Assessment and Response Guide on Injecting Drug Use (Eds. G.V.Stimson, C.Fitch and T.Rhodes). © World Health Organization Correspondence addresses: The Centre for Research Substance Abuse Department on Drugs and Health Behaviour, Cluster on Social Change and Mental Health 200 Seagrave Road, World Health Organization, London, 1211 Geneva 27, SW6 1RQ, Switzerland United Kingdom Tel: 41 22 791 21 11 Fax: 41 22 791 4851 Tel: 44 181 846 6557 email [email protected] Fax: 44 181 846 6505 email [email protected]
    [Show full text]
  • Cost-Effective Interventions That Focus on Most-At-Risk Populations
    Draft Working Paper Cost‐Effective Interventions that Focus on Most‐at‐Risk Populations Swarup Sarkar, Manager, Asia Programs, The Global Fund to Fight AIDS, Tuberculosis and Malaria; principal contributing author, Independent Commission for AIDS in Asia (OUP 2008) Natalie Menser, Research Support Staff, aids2031 Costs and Financing Project, and Department of International Health, Georgetown University William McGreevey, Consulting Health Economist, aids2031 Costs and Financing Project, and Associate Professor, Department of International Health, Georgetown University Draft Working Paper Table of Contents Introduction...............................................................................................................................................5 Denial, disapproval, and behavioural risks among MARPs.......................................................6 Resource needs among MARPs, evolving estimates and approaches.................................8 Benefits and costs of spending to address AIDS prevention among MARPs..................10 Who will pay?..........................................................................................................................................12 Next steps and future projections into 2031...............................................................................16 Tables 1) Global estimate, population of MARPs 2) Asia region country example of resource needs for HIV and AIDS activities, US millions 3) Expenditure on MSM programming, 2004, selected countries and regions (nominal
    [Show full text]